Françoise Drusch

1.2k total citations
17 papers, 924 citations indexed

About

Françoise Drusch is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Françoise Drusch has authored 17 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Françoise Drusch's work include Cervical Cancer and HPV Research (4 papers), Head and Neck Cancer Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Françoise Drusch is often cited by papers focused on Cervical Cancer and HPV Research (4 papers), Head and Neck Cancer Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Françoise Drusch collaborates with scholars based in France, United Kingdom and Australia. Françoise Drusch's co-authors include Philippe Vielh, Ludovic Lacroix, Jean‐Charles Soria, Fanny Billiot, Fabrice André, Sylvestre Le Moulec, Nathalie Jacques, David Planchard, A. Laplanche and Karim Fizazi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Françoise Drusch

17 papers receiving 913 citations

Peers

Countries citing papers authored by Françoise Drusch

Since Specialization

Citations

This map shows the geographic impact of Françoise Drusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Drusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Drusch more than expected).

Fields of papers citing papers by Françoise Drusch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Drusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Drusch. The network helps show where Françoise Drusch may publish in the future.

Co-authorship network of co-authors of Françoise Drusch

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Drusch. A scholar is included among the top collaborators of Françoise Drusch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Drusch. Françoise Drusch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer 2020 ·Cancer Immunology Immunotherapy ·Alexandra Léary, Catherine Genestie, Félix Blanc‐Durand, Sébastien Gouy, Ariane Dunant, Amandine Maulard, Françoise Drusch, Bianca Cheaib, Judith Michels, Enrica Bentivegna, (unknown), Soizick Mesnage, Philippe Morice, Patricia Pautier, (unknown)	25
2	Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative 2018 ·Modern Pathology ·Aurélie Auguste, Catherine Genestie, Marco de Bruyn, Julien Adam, Audrey Le Formal, Françoise Drusch, Patricia Pautier, Emma J. Crosbie, Helen Mackay, Henry C Kitchener, Melanie Powell, Pamela M. Pollock, Linda Mileshkin, Richard J. Edmondson, Remi A. Nout, Hans W. Nijman, Carien L. Creutzberg, Tjalling Bosse, Alexandra Léary	40
3	Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC) 2016 ·Annals of Oncology ·Soizick Mesnage, Aurélie Auguste, Catherine Genestie, Ariane Dunant, (unknown), Françoise Drusch, Sébastien Gouy, Philippe Morice, Enrica Bentivegna, C. Lhommé, Patricia Pautier, Judith Michels, Audrey Le Formal, Bianca Cheaib, Julien Adam, Alexandra Léary	138
4	Diagnosis of HPV driven oropharyngeal cancers: Comparing p16 based algorithms with the RNAscope HPV-test 2016 ·Oral Oncology ·H. Mirghani, Odile Casiraghi, Joanne Guerlain, Furrat Amen, Ming‐Xiao He, Xiaojun Ma, Yuling Luo, (unknown), Françoise Drusch, (unknown), Antoine E. Melkane, (unknown), Cécile Badoual, Jean‐Yves Scoazec, Isabelle Borget, Anne Aupérin, Véronique Dalstein, Philippe Vielh	44
5	Whole exome sequencing of rare aggressive breast cancer histologies 2016 ·Breast Cancer Research and Treatment ·Maria Vittoria Dieci, (unknown), Véronique Scott, Guangliang Yin, Ran Xu, Philippe Vielh, (unknown), Cécile Vicier, Mélanie Laporte, Françoise Drusch, Valentina Guarneri, Pierfranco Conté, Suzette Delaloge, Ludovic Lacroix, Olivia Fromigué, Fabrice André, Céline Lefèbvre	32
6	Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice 2015 ·Modern Pathology ·H. Mirghani, Odile Casiraghi, Furrat Amen, Ming‐Xiao He, Xiaojun Ma, Patrick Saulnier, Ludovic Lacroix, Françoise Drusch, (unknown), Jean Lacau Saint Guily, Cécile Badoual, Jean‐Yves Scoazec, Philippe Vielh	80
7	Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer 2013 ·British Journal of Cancer ·Nathalie Chaput, Magali Svrcek, A. Aupérin, Clara Locher, Françoise Drusch, David Malka, Julien Taı̈eb, Diane Goèré, Michel Ducreux, Valérie Boige	40
8	Oropharyngeal cancers: Significance of HPV16 detection in neck lymph nodes 2013 ·Journal of Clinical Virology ·H. Mirghani, (unknown), (unknown), (unknown), Furrat Amen, Ingrid Breuskin, Marine Lefèvre, Odile Casiraghi, Françoise Drusch, Patrick Soussan, Philippe Vielh, Jean Lacau St Guily	8
9	Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+T cells 2013 ·BMC Cancer ·Meriem Hasmim, Cécile Badoual, Philippe Vielh, Françoise Drusch, Virginie Marty, Agnès Laplanche, Mariana O. Diniz, Hélène Roussel, Éléonore De Guillebon, Stéphane Oudard, Stéphane Hans, Éric Tartour, Salem Chouaı̈b	17
10	Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas 2013 ·Head & Neck ·Antoine E. Melkane, Anne Aupérin, Patrick Saulnier, Ludovic Lacroix, Philippe Vielh, Odile Casiraghi, (unknown), Françoise Drusch, Stéphane Temam	32
11	Circulating Tumor Cells in Lung Cancer 2012 ·Acta Cytologica ·(unknown), Emma Pailler, Fanny Billiot, Françoise Drusch, Amélie Barthelemy, Marianne Oulhen, Benjamin Besse, Jean‐Charles Soria, Françoise Farace, Philippe Vielh	55
12	A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas 2011 ·British Journal of Cancer ·F Farace, Christophe Massard, Nadège Vimond, Françoise Drusch, Nathalie Jacques, Fanny Billiot, A. Laplanche, Anne Chauchereau, Ludovic Lacroix, David Planchard, Sylvestre Le Moulec, Fabrice André, Karim Fizazi, Jean‐Charles Soria, Philippe Vielh	325
13	Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissues sarcomas 2011 ·European Journal of Cancer ·(unknown), Nathalie Auger, Elodie Tournay, Gonzalo Gomez-Abuin, Philippe Terrier, Françoise Drusch, Julien Dômont, Angela Cioffi, Bérénice Boulet, (unknown), (unknown), Jean Bénard, Sylvie Bonvalot, (unknown)	19
14	Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis 2010 ·PLoS ONE ·Matthieu Peyre, Frédéric Commo, Carmela Dantas-Barbosa, Felipe Andreiuolo, Stéphanie Puget, Ludovic Lacroix, Françoise Drusch, Véronique Scott, Pascale Varlet, Audrey Mauguen, Philippe Dessen, Vladimir Lazar, Gilles Vassal, Jacques Grill	31
15	Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer 2007 ·Annals of Oncology ·Franck Meslin, Rosa Conforti, Chafika Mazouni, N. Costedoat‐Chalumeau, Gorana Tomasic, Françoise Drusch, (unknown), Jean‐Christophe Sabourin, Jacques Grassi, Suzette Delaloge, (unknown), Salem Chouaı̈b, Fabrice André, Maryam Mehrpour	36
16	Can ERCC1 and topoisomerase II-alpha predict histological response and outcome after induction chemotherapy in locally advanced soft tissue sarcomas (LASTS)? 2007 ·Journal of Clinical Oncology ·Rodrigo Ruiz-Soto, Nathalie Auger, Marine Castaing, Françoise Drusch, Sylvie Bonvalot, Philippe Terrier, C. Le Péchoux, Julien Dômont, Jean Bénard, Axel Le Cesne	1
17	Genome-wide expression profiling and tissue array analysis for prediction of recurrences in stage II-III colorectal cancer (CRC) 2006 ·Journal of Clinical Oncology ·Valérie Boige, Magali Svrcek, Stefan Michiels, Marc Pocard, Vincent Laville, Françoise Drusch, Jean‐Christophe Sabourin, Philippe Dessen, Michel Ducreux, Vladimir Lazar	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact